Pfizer (PFE) Total Current Liabilities (2009 - 2026)

Pfizer (PFE) has 18 years of Total Current Liabilities data on file, last reported at $34.3 billion in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $34.3 billion, down 5.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.3 billion (down 5.77% YoY), and the FY2025 annual result was $37.0 billion, down 13.98% from the prior year.
• Total Current Liabilities fell to $34.3 billion in Q1 2026 per PFE's latest filing, from $37.0 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $47.8 billion in Q4 2023 and troughed at $5.2 billion in Q4 2022.
• A 5-year average of $37.5 billion and a median of $37.7 billion in 2025 frame the typical range for Total Current Liabilities.
• On a YoY basis, Total Current Liabilities climbed as much as 494.77% in 2023 and fell as far as 26.92% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $42.1 billion in 2022, then grew by 13.42% to $47.8 billion in 2023, then slipped by 10.04% to $43.0 billion in 2024, then declined by 13.98% to $37.0 billion in 2025, then fell by 7.13% to $34.3 billion in 2026.
• Business Quant data shows PFE's Total Current Liabilities at $34.3 billion in Q1 2026, $37.0 billion in Q4 2025, and $36.6 billion in Q3 2025.